EVERO Drug-coated Balloon (DCB) Randomized Trial
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- Cook Research Incorporated
- Study ID
- NCT07144150
- Status
- Recruiting
Conditions
- Peripheral Arterial Disease
- Peripheral Vascular Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Evero DCB — COMBINATION_PRODUCTPTA with a DCB in de novo or restenotic lesions in native superficial femoral and popliteal arteries
- Paclitaxel DCB — COMBINATION_PRODUCTPTA with a DCB in de novo or restenotic lesions in native superficial femoral and popliteal arteries
Study Details
The primary objective of the study is to evaluate the long-term safety and effectiveness of the Advance Evero™ 18 Everolimus-coated Percutaneous Transluminal Angioplasty Balloon Catheter (hereafter referred to as the Evero drug-coated balloon \[DCB\]) in the treatment of the femoropopliteal artery lesions in patients with peripheral arterial disease (PAD). Specifically, the Randomized-Controlled Trial (RCT) is designed to demonstrate non-inferior safety and non-inferior effectiveness of the Evero DCB when compared to commercially available paclitaxel DCBs (pDCBs).
Key Dates
- Start date
- Apr 17, 2026
- Status verified
- Jun 2026
- Primary completion
- Sep 30, 2028
- Completion
- Oct 31, 2032
Study Design
- Enrollment
- 410 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Evero DCBTreatment with Evero drug-coated balloon to apply local treatment with everolimus
- Active Comparator: Paclitaxel-coated DCBTreatment with commercially-available drug-coated balloons to apply local treatment with paclitaxel
Primary Outcome Measure
Primary safety endpoint [ Time Frame: 30 days (death); 12 months (amputation and CD-TLR) ]
Central Contacts
- Noah Shields765-463-7537
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Cardiac and Vascular Institute | Gainesville | Florida | 32605 | - |
| Baptist Cardiac and Vascular Institute | Miami | Florida | 33176 | - |
| Prisma Health Memorial | Greenville | South Carolina | 26905 | - |
Find similar trials in Gainesville, FL
Related Studies
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPHASE3 · Recruiting · Population Health Research Institute · New Haven, Connecticut
- SELUTION4BTK TrialRecruiting · M.A. Med Alliance S.A. · Chandler, Arizona
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaRecruiting · LimFlow, Inc. · La Jolla, California
- The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive DiseaseRecruiting · W.L.Gore & Associates · Little Rock, Arkansas